Sibira Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2022.
2022 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Sibira Pharma Private Limited

Sibira Pharma Private Limited, a active private limited company, was established on 05 September 2022 in Hyderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239TG2022PTC166314. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Divya Balasubramanian (Director), Bandi Chandana (Additional Director), Payel Sarkar (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at H No.1119 &1121, Sy No.165, Phase-V Dhoolapally Road, Adj. Jeedimetla, Hyderabad, Telangana, 500055.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2022PTC166314

  • Registration Number

    166314

  • Incorporation Date

    05 September 2022

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 5 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Sibira Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sibira Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sibira Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Divya Balasubramanian Director 05 Sep 2022 Current
Bandi Chandana Additional Director 27 Jan 2024 Current
Payel Sarkar Director 05 Sep 2022 Current
Sangarappan Sivakumar Director 05 Sep 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sibira Pharma.

Enhance accessibility to Sibira Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sibira Pharma revenue growth over time
Sibira Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sibira Pharma?

Unlock access to Sibira Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sibira Pharma?

Sibira Pharma has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sibira Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sibira Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sibira Pharma
Recent Activity within the Organization
  • Director Appointment

    Progress on Bandi Chandana was appointed as a Additional Director was appointed as a Additional Director on 27 Jan 2024 & has been associated with this company since 2 years 1 month . was documented.

  • Annual General Meeting

    Progress on Sibira Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Sibira Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was documented.

  • Director Appointment

    Progress on Divya Balasubramanian was appointed as a Director was appointed as a Director on 05 Sep 2022 & has been associated with this company since 3 years 5 months . was documented.

  • Director Appointment

    Progress on Payel Sarkar was appointed as a Director was appointed as a Director on 05 Sep 2022 & has been associated with this company since 3 years 5 months . was documented.

  • Director Appointment

    Sangarappan Sivakumar was appointed as a Director was appointed as a Director on 05 Sep 2022 & has been associated with this company since 3 years 5 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sibira Pharma Private Limited?

The CIN of Sibira Pharma Private Limited is U24239TG2022PTC166314.

Where is Sibira Pharma Private Limited headquartered?

Sibira Pharma Private Limited is headquartered at H No.1119 &1121, Sy No.165, Phase-V Dhoolapally Road, Adj. Jeedimetla, Hyderabad, Telangana, 500055.

When was Sibira Pharma Private Limited incorporated?

Sibira Pharma Private Limited was incorporated on 05 September 2022.

Who are the current directors of Sibira Pharma Private Limited?

The current directors of Sibira Pharma Private Limited are

What is the primary industry of Sibira Pharma Private Limited?

The primary industry of Sibira Pharma Private Limited is Chemicals.

Is Sibira Pharma Private Limited a listed company?

Sibira Pharma Private Limited is unlisted.

What is the capital structure of Sibira Pharma Private Limited?

The authorized capital of Sibira Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available